| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Siyang Liu, Heng Wan, Sheng Nie, Huanyi Cao, Lan Liu, Hua Liang, Hong Xu, Bicheng Liu, Chunbo Chen, Huafeng Liu, Qiongqiong Yang, Hua Li, Yaozhong Kong, Guisen Li, Qijun Wan, Yan Zha, Ying Hu, Gang Xu, Yongjun Shi, Yilun Zhou, Guobin Su, Ying Tang, Mengchun Gong, Aixin Guo, Jianping Weng, Hongjiang Wu, Fan Fan Hou, Jie She. Dipeptidyl peptidase 4 inhibitors vs. metformin for new-onset dementia: a propensity score-matched cohort study. The Journal of clinical endocrinology and metabolism. 2024-04-23. PMID:38652239. |
our objective was to investigate whether the initiation of dpp4 inhibitors, as opposed to metformin, was linked to a reduced risk of dementia. |
2024-04-23 |
2024-04-26 |
Not clear |
| Siyang Liu, Heng Wan, Sheng Nie, Huanyi Cao, Lan Liu, Hua Liang, Hong Xu, Bicheng Liu, Chunbo Chen, Huafeng Liu, Qiongqiong Yang, Hua Li, Yaozhong Kong, Guisen Li, Qijun Wan, Yan Zha, Ying Hu, Gang Xu, Yongjun Shi, Yilun Zhou, Guobin Su, Ying Tang, Mengchun Gong, Aixin Guo, Jianping Weng, Hongjiang Wu, Fan Fan Hou, Jie She. Dipeptidyl peptidase 4 inhibitors vs. metformin for new-onset dementia: a propensity score-matched cohort study. The Journal of clinical endocrinology and metabolism. 2024-04-23. PMID:38652239. |
hypoglycemic pharmacotherapy interventions for alleviating the risk of dementia remains controversial, particularly about dipeptidyl peptidase 4 (dpp4) inhibitors versus metformin. |
2024-04-23 |
2024-04-26 |
Not clear |
| Che-Yuan Wu, Carina Iskander, Christa Wang, Lisa Y Xiong, Baiju R Shah, Jodi D Edwards, Moira K Kapral, Nathan Herrmann, Krista L Lanctôt, Mario Masellis, Richard H Swartz, Hugo Cogo-Moreira, Bradley J MacIntosh, Jennifer S Rabin, Sandra E Black, Refik Saskin, Walter Swardfage. Association of sulfonylureas with the risk of dementia: A population-based cohort study. Journal of the American Geriatrics Society. 2023-05-23. PMID:37218376. |
the objective was to determine whether sulfonylurea use was associated with a differential risk of dementia compared with dipeptidyl peptidase-4 (dpp4) inhibitor use. |
2023-05-23 |
2023-08-14 |
Not clear |
| Yuan Fang, Margaret F Doyle, Jiachen Chen, Michael L Alosco, Jesse Mez, Claudia L Satizabal, Wei Qiao Qiu, Joanne M Murabito, Kathryn L Lunett. Association between inflammatory biomarkers and cognitive aging. PloS one. vol 17. issue 9. 2022-09-09. PMID:36083988. |
we examined the association of 11 plasma proteins (cd14, cd163, cd5l, cd56, cd40l, cxcl16, sdf1, dpp4, sgp130, srage, and mpo) related to immune and inflammatory responses with measures of cognitive function, brain mri and dementia risk. |
2022-09-09 |
2023-08-14 |
human |
| Jonathan V Mui, Jiandong Zhou, Sharen Lee, Keith Sai Kit Leung, Teddy Tai Loy Lee, Oscar Hou In Chou, Shek Long Tsang, Abraham Ka Chung Wai, Tong Liu, Wing Tak Wong, Carlin Chang, Gary Tse, Qingpeng Zhan. Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors vs. Dipeptidyl Peptidase-4 (DPP4) Inhibitors for New-Onset Dementia: A Propensity Score-Matched Population-Based Study With Competing Risk Analysis. Frontiers in cardiovascular medicine. vol 8. 2021-11-10. PMID:34746262. |
sodium-glucose cotransporter 2 (sglt2) inhibitors vs. dipeptidyl peptidase-4 (dpp4) inhibitors for new-onset dementia: a propensity score-matched population-based study with competing risk analysis. |
2021-11-10 |
2023-08-13 |
Not clear |
| Joshua C Bis, Charles DeCarli, Albert Vernon Smith, Fedde van der Lijn, Fabrice Crivello, Myriam Fornage, Stephanie Debette, Joshua M Shulman, Helena Schmidt, Velandai Srikanth, Maaike Schuur, Lei Yu, Seung-Hoan Choi, Sigurdur Sigurdsson, Benjamin F J Verhaaren, Anita L DeStefano, Jean-Charles Lambert, Clifford R Jack, Maksim Struchalin, Jim Stankovich, Carla A Ibrahim-Verbaas, Debra Fleischman, Alex Zijdenbos, Tom den Heijer, Bernard Mazoyer, Laura H Coker, Christian Enzinger, Patrick Danoy, Najaf Amin, Konstantinos Arfanakis, Mark A van Buchem, Renée F A G de Bruijn, Alexa Beiser, Carole Dufouil, Juebin Huang, Margherita Cavalieri, Russell Thomson, Wiro J Niessen, Lori B Chibnik, Gauti K Gislason, Albert Hofman, Aleksandra Pikula, Philippe Amouyel, Kevin B Freeman, Thanh G Phan, Ben A Oostra, Jason L Stein, Sarah E Medland, Alejandro Arias Vasquez, Derrek P Hibar, Margaret J Wright, Barbara Franke, Nicholas G Martin, Paul M Thompson, Michael A Nalls, Andre G Uitterlinden, Rhoda Au, Alexis Elbaz, Richard J Beare, John C van Swieten, Oscar L Lopez, Tamara B Harris, Vincent Chouraki, Monique M B Breteler, Philip L De Jager, James T Becker, Meike W Vernooij, David Knopman, Franz Fazekas, Philip A Wolf, Aad van der Lugt, Vilmundur Gudnason, W T Longstreth, Matthew A Brown, David A Bennett, Cornelia M van Duijn, Thomas H Mosley, Reinhold Schmidt, Christophe Tzourio, Lenore J Launer, M Arfan Ikram, Sudha Seshadr. Common variants at 12q14 and 12q24 are associated with hippocampal volume. Nature genetics. vol 44. issue 5. 2012-07-02. PMID:22504421. |
these associations implicate genes related to apoptosis (hrk), development (wif1), oxidative stress (msr3b), ubiquitination (fbxw8) and neuronal migration (astn2), as well as enzymes targeted by new diabetes medications (dpp4), indicating new genetic influences on hippocampal size and possibly the risk of cognitive decline and dementia. |
2012-07-02 |
2023-08-12 |
Not clear |